Saroja Pharma Industries India Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Saroja Pharma Industries India has been growing earnings at an average annual rate of 18.5%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 0.2% per year. Saroja Pharma Industries India's return on equity is 6%, and it has net margins of 2.2%.
Anahtar bilgiler
18.5%
Kazanç büyüme oranı
-38.2%
EPS büyüme oranı
| Healthcare Sektör Büyümesi | 29.4% |
| Gelir büyüme oranı | 0.2% |
| Özkaynak getirisi | 6.0% |
| Net Marj | 2.2% |
| Son Kazanç Güncellemesi | 31 Mar 2024 |
Yakın geçmiş performans güncellemeleri
Gelir ve Gider Dağılımı
Saroja Pharma Industries India nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Mar 24 | 407 | 9 | 16 | 0 |
| 31 Dec 23 | 427 | 9 | 16 | 0 |
| 30 Sep 23 | 448 | 10 | 16 | 0 |
| 30 Jun 23 | 475 | 10 | 16 | 0 |
| 31 Mar 23 | 502 | 11 | 16 | 0 |
| 31 Mar 22 | 556 | 11 | 13 | 0 |
| 31 Mar 21 | 367 | 7 | 10 | 0 |
| 31 Mar 20 | 171 | 2 | 8 | 0 |
Kaliteli Kazançlar: SAROJA has a high level of non-cash earnings.
Büyüyen Kar Marjı: SAROJA's current net profit margins (2.2%) are higher than last year (2.1%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: SAROJA's earnings have grown by 18.5% per year over the past 5 years.
Büyüme Hızlandırma: SAROJA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: SAROJA had negative earnings growth (-17.2%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).
Özkaynak Getirisi
Yüksek ROE: SAROJA's Return on Equity (6%) is considered low.